This product is not a reference material or analytical standard. Please see the links below to review Butorphanol Tartrate standards that are currently available:
https://www.sigmaaldrich.com/product/cerillian/b037
https://www.sigmaaldrich.com/product/usp/1082504
B9156
Butorphanol (+)-tartrate salt
≥99%
Synonym(s):
L-N-Cyclobutylmethyl-3,14-dihydroxymorphinan (+)-tartrate salt
Sign In to View Organizational & Contract Pricing
Select a Size
Pricing and availability is not currently available.
About This Item
Empirical Formula (Hill Notation):
C21H29NO2 · C4H6O6
CAS Number:
Molecular Weight:
477.55
EC Number:
MDL number:
UNSPSC Code:
12352200
PubChem Substance ID:
NACRES:
NA.77
Skip To
Assay
≥99%
form
powder
drug control
USDEA Schedule IV; psychotrope (France); regulated under CDSA - not available from Sigma-Aldrich Canada
originator
Bristol-Myers Squibb
storage temp.
2-8°C
SMILES string
O[C@H]([C@@H](O)C(O)=O)C(O)=O.Oc1ccc2C[C@H]3N(CC[C@@]4(CCCC[C@@]34O)c2c1)CC5CCC5
InChI
1S/C21H29NO2.C4H6O6/c23-17-7-6-16-12-19-21(24)9-2-1-8-20(21,18(16)13-17)10-11-22(19)14-15-4-3-5-15;5-1(3(7)8)2(6)4(9)10/h6-7,13,15,19,23-24H,1-5,8-12,14H2;1-2,5-6H,(H,7,8)(H,9,10)/t19-,20+,21-;1-,2-/m11/s1
InChI key
GMTYREVWZXJPLF-BTVKVFNOSA-N
Gene Information
human ... OPRK1(4986), OPRM1(4988)
Looking for similar products? Visit Product Comparison Guide
Related Categories
1 of 4
This Item | L5143 | A0937 | 489350 |
|---|---|---|---|
| assay ≥99% | assay ≥98% (HPLC) | assay - | assay ≥97% (LC/MS) |
| form powder | form powder | form powder | form crystalline solid |
| drug control USDEA Schedule IV; psychotrope (France); regulated under CDSA - not available from Sigma-Aldrich Canada | drug control USDEA Schedule II; Home Office Schedule 2; stupéfiant (France); kontrollierte Droge in Deutschland; regulated under CDSA - not available from Sigma-Aldrich Canada; estupefaciente (Spain); Decreto Lei 15/93: Tabela IA (Portugal) | drug control - | drug control - |
| Quality Level 200 | Quality Level 200 | Quality Level 200 | Quality Level 100 |
| storage temp. 2-8°C | storage temp. - | storage temp. - | storage temp. 2-8°C |
| originator Bristol-Myers Squibb | originator - | originator - | originator - |
Biochem/physiol Actions
κ/μ opioid receptor agonist.
Features and Benefits
This compound was developed by Bristol-Myers Squibb. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.
used together
Product No.
Description
Pricing
Signal Word
Warning
Hazard Statements
Precautionary Statements
Hazard Classifications
Acute Tox. 4 Oral - Repr. 2
Storage Class Code
11 - Combustible Solids
WGK
WGK 3
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Personal Protective Equipment
dust mask type N95 (US), Eyeshields, Gloves
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
J A Vivian et al.
The Journal of pharmacology and experimental therapeutics, 290(1), 259-265 (1999-06-25)
Butorphanol and nalbuphine have substantial affinity for mu and kappa-opioid receptor sites, yet their behavioral effects in monkeys are largely consistent with a mu receptor mechanism of action. Using ethylketocyclazocine (EKC) discrimination and diuresis assays in rhesus monkeys (Macaca mulatta)
J C Chen et al.
Life sciences, 52(4), 389-396 (1993-01-01)
The ability of morphine, fentanyl, butorphanol, nalbuphine, and dezocine to compete with radiolabeled ligands for binding at the mu1, mu2, kappa1, and delta opioid receptors and the sigma receptor was characterized. In the absence of sodium, the potency of opioid
Chromatograms
application for HPLC
-
Can this material (Cod: B9156 Butorphanol) be used as a reference standard or analytical standard?
1 answer-
Helpful?
-
Active Filters
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service